<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04506736</url>
  </required_header>
  <id_info>
    <org_study_id>6204</org_study_id>
    <nct_id>NCT04506736</nct_id>
  </id_info>
  <brief_title>Open Lung Approach Versus Conventional Protective Ventilation in Obese Patients Undergoing Open Abdominal Surgery</brief_title>
  <official_title>Open Lung Approach Versus Conventional Protective Ventilation in Obese Patients Undergoing Open Abdominal Surgery: A Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Zagazig University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Zagazig University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      the purpose of this study is to compare open lung approach versus conventional protective&#xD;
      ventilation in obese patients undergoing open abdominal surgery&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      after being informed about the study and potential risks. All patients giving written consent&#xD;
      will be randomized by double blind manner into 2 groups each one containing 24 patients Group&#xD;
      SPV: will be ventilated using volume controlled ventilation (7ml/kg tidal volume) with&#xD;
      addition of 5 cm H₂O fixed PEEP till the end of the surgery .&#xD;
&#xD;
      Group OLA: The patients will undergo ARM followed by personalized PEEP.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 30, 2020</start_date>
  <completion_date type="Actual">April 20, 2021</completion_date>
  <primary_completion_date type="Actual">March 30, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Participant, Care Provider</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>post-operative pulmonary complications</measure>
    <time_frame>one week postoperative</time_frame>
    <description>Pulmonary function tests will be done before surgery as a baseline then repeated after the surgery when the patient is fully awake using bedside spirometer in the sitting position.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>heart rate</measure>
    <time_frame>Baseline (before surgery) and intraoperative</time_frame>
    <description>hemodynamic changes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>airway pressure</measure>
    <time_frame>intraoperative</time_frame>
    <description>During mechanical ventilation airway pressures will be continuously monitored.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pulmonary complications.</measure>
    <time_frame>one week postoperative</time_frame>
    <description>1. Postoperative pulmonary complications which are defined as having one or more of the following: 1.Pneumonia 2. Respiratory failure requiring mechanical ventilation (Postoperative PaO2 &lt; 60 mm Hg on room air, a PaO2:FiO2 ratio &lt; 300 mm Hg) or peripheral oxygen saturation (SpO₂) &lt;90% and requiring oxygen therapy ). 3. Atelectasis requiring bronchoscopic intervention 4. Pulmonary edema ( postoperative acute lung injury or ARDS). 5. Delayed tracheal extubation ( &gt;24 hours postoperatively) or need for reintubation (because of respiratory distress, hypoxia, hypercarbia, or respiratory acidosis). 6. Pneumothorax 7. Bronchospasm (Newly detected refractory expiratory wheeze requiring bronchodilators</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>length of hospital stay,</measure>
    <time_frame>postoperative up to one month</time_frame>
    <description>the length of hospital stay, and 30 days mortality.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mean arterial blood pressure</measure>
    <time_frame>Baseline (before surgery) and intraoperative</time_frame>
    <description>hemodynamic changes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ETCO2</measure>
    <time_frame>Baseline (before surgery) and intraoperative</time_frame>
    <description>hemodynamic changes</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>tidal volume</measure>
    <time_frame>intraoperative</time_frame>
    <description>During mechanical ventilation tidal volume will be continuously monitored.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SpO2</measure>
    <time_frame>Baseline (before surgery) and intraoperative</time_frame>
    <description>hemodynamic changes</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">48</enrollment>
  <condition>Abdominal Surgery</condition>
  <condition>Obese Patients</condition>
  <arm_group>
    <arm_group_label>SPV spontanous ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will be ventilated using volume controlled ventilation (7ml/kg tidal volume) with addition of 5 cm H₂O fixed PEEP till the end of the surgery .</description>
  </arm_group>
  <arm_group>
    <arm_group_label>OLA open lung ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>The patients will undergo ARM followed by personalized PEEP.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>ARM</intervention_name>
    <description>The ARM is performed by setting the peak inspiratory pressure to 45 cmH₂O then changing the mode of ventilation to pressure controlled ventilation (PCV) with the inspiratory pressure set to give a tidal volume equal to that given during VCV, I:E ratio of 1:1 and a PEEP of 5 cmH₂O. The PEEP level is then increased in 5 cmH₂O steps every minute till it reaches 20 cmH₂O and inspiratory pressure is increased to get an airway opening pressure (inspiratory pressure + PEEP) of 40 cmH₂O which is maintained for one minute after which the ventilation returned to the original setting except for the PEEP level which is kept at 20 cmH₂O.&#xD;
The titration of individualized PEEP is done by decremental reduction of the 20 cmH₂O PEEP level in 2 cmH₂O steps every 2 minutes and measuring static compliance of the respiratory system (CRS) at each step.</description>
    <arm_group_label>OLA open lung ventilation</arm_group_label>
    <other_name>followed by personalized PEEP.</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>spontanous ventilation</intervention_name>
    <description>volume controlled ventilation (7ml/kg tidal volume) with addition of 5 cm H₂O fixed PEEP till the end of the surgery .</description>
    <arm_group_label>SPV spontanous ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patient aged between 18 - 65 years&#xD;
&#xD;
          -  BMI between 30-40 kg/m²&#xD;
&#xD;
          -  ASA I and II,open elective abdominal surgery which is expected to last for more than 2&#xD;
             hours under general anesthesia and planned to be extubated at the end of surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Emergency surgery, pregnancy, chronic obstructive pulmonary disease (FEV1 &lt; 80% of the&#xD;
             predicted value)&#xD;
&#xD;
          -  active asthma, acute respiratory distress syndrome&#xD;
&#xD;
          -  history of pneumothorax, lung cyst, Difficult airway, obstructive sleep apnea,ischemic&#xD;
             heart disease, heart failure&#xD;
&#xD;
          -  significant arrhythmias and intracranial hypertension. Exposure to radiotherapy and&#xD;
             chemotherapy within 2 months before surgery. Advanced Cardiovascular ,liver, renal&#xD;
             diseases ischemic heart disease, heart failure, significant arrhythmias and&#xD;
             intracranial hypertension&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Howida A kamal, M.D</last_name>
    <role>Study Director</role>
    <affiliation>zagazig U</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Faculty of Medicine,Zagazig University</name>
      <address>
        <city>Zagazig</city>
        <state>Zagazig, Elsharkia,egypt</state>
        <zip>44519</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>July 24, 2020</study_first_submitted>
  <study_first_submitted_qc>August 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 10, 2020</study_first_posted>
  <last_update_submitted>April 24, 2021</last_update_submitted>
  <last_update_submitted_qc>April 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 27, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Zagazig University</investigator_affiliation>
    <investigator_full_name>Marwa Mohamed Medhat</investigator_full_name>
    <investigator_title>lecture of anesthesia and surgical intensive care (Principal Investigator)</investigator_title>
  </responsible_party>
  <keyword>Open lung approach</keyword>
  <keyword>conventional ventilation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

